Description
The DeepChek®Assay-HBV RT Genotyping and Drug Resistance V1 (RUO) is intended to be used for HBV genotyping, drug resistance and vaccine escape assessment. It provides drug susceptibility information for viral HBV Polymerase inhibitors. It combines target-specific PCR reagents with in vitro diagnostic software both compatible with either Sanger or Next Generation Sequencing platforms.
Methodology
DNA Sequencing • Polymerase Chain Reaction (PCR)
More information on the DeepChek® Assays – Click here
More information on the DeepChek® Software – Click here
More information on the SeqHepB® Software – Click here
CHARACTERISTICS AND PERFORMANCES
EXAMPLES OF REPORTS
For SANGER sequencing
SeqHepB Report
Ordering information
Related products
DEEPCHEK® ASSAYS
Sequencing-based genotyping assays for microbiolog…
The DeepChek® Assay product line combines target-specific PCR reagents with in vitro diagnostic software both compatible with either Sanger or Next Ge…
SeqHepB
As treatment options for the management of Hepatitis B continue to grow, the clinician's challenge to manage drug selection in the face of single and…